Von Hippel-Lindau Gene

What the Von Hippel-Lindau Gene Means

The Von Hippel-Lindau gene, often called the VHL gene, is a gene that produces a protein important for controlling how cells grow, divide, and function. This protein acts like a brake to prevent cells from growing too quickly or in an uncontrolled way. Everyone has two copies of the VHL gene—one inherited from each parent. Sometimes, changes called mutations happen in the VHL gene. These mutations can stop the gene from working properly, which may lead to abnormal cell growth.

When the VHL gene is mutated, it can cause a rare inherited condition called Von Hippel-Lindau syndrome. This syndrome increases the risk of developing tumors in various parts of the body, including the kidneys, brain, spinal cord, eyes, adrenal glands, and pancreas.

Why the VHL Gene Matters in Cancer Care

Von Hippel-Lindau syndrome raises the chance of developing certain tumors, especially a type of kidney cancer called clear cell renal cell cancer. Because this syndrome is inherited, it can affect multiple family members across generations. Knowing if someone has a mutation in the VHL gene helps doctors identify who is at higher risk for these tumors.

This information can guide doctors and patients in making decisions about screening and monitoring to catch tumors early or manage them effectively. It may also influence treatment choices and follow-up care.

What Patients Might See or Hear About the VHL Gene

If the VHL gene comes up in your medical records, test results, or conversations with your healthcare team, it might be related to genetic testing or a diagnosis of Von Hippel-Lindau syndrome. You may hear about genetic counseling, where a trained professional helps you understand your family history, the risks of inherited conditions, and whether genetic testing is appropriate for you.

People with a family history of kidney cancer, multiple tumors, or early-onset kidney cancer may be offered genetic testing to check for changes in the VHL gene. Testing usually involves a blood or saliva sample.

Where the Term Might Appear

The term "VHL gene" can appear in genetic test reports, treatment plans, visit notes, or educational materials about hereditary kidney cancer syndromes. It may also come up when discussing clinical trials or targeted therapies related to tumors caused by VHL mutations.

What the Term Does Not Automatically Mean

Finding a change in the VHL gene does not mean a person definitely has cancer or will develop tumors. It means there is an increased risk. Many people with VHL gene mutations live with careful monitoring and early treatment to manage their health. Also, most kidney cancers happen without inherited gene mutations, so not all kidney cancers are caused by changes in the VHL gene.

Common Questions to Ask Your Care Team

If the VHL gene is part of your care discussion, you might ask: What does this gene change mean for my health? Should my family members be tested? What screening or monitoring should I have? Are there treatments or clinical trials available for tumors linked to VHL? How will this affect my long-term care plan?

Safety and Next Steps

This information is educational and does not replace medical advice. If the VHL gene is mentioned in your medical records or test results, the best next step is to talk with your healthcare team or a genetic counselor. They can explain what the findings mean for you and your family and help guide appropriate care and monitoring.